Israel-based Phoenix Financial acquired more than 3.5 million additional shares of Teva Pharmaceuticals for an estimated $62.1 million in the third quarter. Post-transaction, the fund reported holding ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback